Massachusetts General Hospital
Cambridge
Dr. Galit Frydman holds a Doctorate of Veterinary Medicine from the University of Florida and a Doctorate of Science in Biological Engineering from the Massachusetts Institute of Technology. She holds academic appointments in the Division of Trauma, Emergency Surgery and Surgical Critical Care (Dept of Surgery, Massachusetts General Hospital) and in the Division of Comparative Medicine (Dept of Biological Engineering, Massachusetts Institute of Technology). Dr. Frydman is also the President and Chief Science Officer at Coagulo Medical Technologies, Inc. Her current research focuses on the exploration of new mechanisms and the discovery of new drug targets for immunothrombosis during severe inflammatory states.
Disclosure information not submitted.
Monday, April 18, 2022
7:00 AM – 8:00 AM US CST
Monday, April 18, 2022
7:00 AM – 8:00 AM US CST
Monday, April 18, 2022
7:00 AM – 8:00 AM US CST